ASX-listed biotech company BioDiem is focused on developing vaccine and therapies for infectious diseases and turned over $1.33 million last…
ASX-listed biotech company BioDiem is focused on developing vaccine and therapies for infectious diseases and turned over $1.33 million last…
Biotech company Virax has collapsed with Laurie Fitzgerald and Stephen Dixon of Grant Thornton appointed as administrators last week. Vir…
A Perth specialist life science company will use a $1 million grant from Commercialisation Australia to develop biomarkers for diabetic kidn…
It’s been quite a year for internet entrepreneurs. While investments in the online space have been occurring for some time, 2012 has be…
A Victoria-based company plans to commercialise breakthrough technology for patients with Parkinson’s disease, after securing $3.5 million i…
Should the Australian business community be happy or sad to see one of its biotech pioneers ink a merger deal with a US company and move its…
After a rough few years for the Australian biotech sector, it’s worth checking in on the industry again and celebrating some of the small bu…
The idea of Australia having a “two speed” economy has become so entrenched that it’s easy to overlook the less visible, but yet signi…
Indian researchers say they are close to developing an “electronic nose” to sniff out tuberculosis on the breath, offering rapid diagnos…
The Victorian Government plans to spend more than $50 million on the state’s biotechnology sector, just days after IBM announced a new R&a…
Start-ups seeking major investment are facing “warzone” conditions, with the situation potentially set to worsen due to the European deb…
V-Tol Aerospace, a Queensland based company that develops unmanned aircraft systems, has teamed up with the University of Queensland to laun…
